150 related articles for article (PubMed ID: 8341311)
1. Brain glucose metabolism and dopamine D2 receptor analysis in a patient with hemiparkinsonism-hemiatrophy syndrome.
Przedborski S; Goldman S; Levivier M; Giladi N; Bidaut LM; Hildebrand J; Stanus E; Labar D; Luxen A
Mov Disord; 1993 Jul; 8(3):391-5. PubMed ID: 8341311
[TBL] [Abstract][Full Text] [Related]
2. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
[TBL] [Abstract][Full Text] [Related]
3. [PET study of dopamine metabolism and dopamine D2 receptor in juvenile parkinsonism].
Tanji H; Nagasawa H; Itoh M; Itoyama Y
Nihon Rinsho; 1997 Jan; 55(1):89-94. PubMed ID: 9014428
[TBL] [Abstract][Full Text] [Related]
4. [Is functional imaging useful in the clinical evaluation of Parkinson's disease?].
Remy P
Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S57-61. PubMed ID: 12773889
[TBL] [Abstract][Full Text] [Related]
5. Metabolic topography of the hemiparkinsonism-hemiatrophy syndrome.
Przedborski S; Giladi N; Takikawa S; Ishikawa T; Dhawan V; Spetsieris P; Chaly T; Fahn S; Eidelberg D
Neurology; 1994 Sep; 44(9):1622-8. PubMed ID: 7936286
[TBL] [Abstract][Full Text] [Related]
6. Suite PET/CT neuroimaging for the diagnosis of Parkinson's disease: statistical parametric mapping analysis.
Wang R; Xu B; Guo Z; Chen T; Zhang J; Chen Y; Zhu H
Nucl Med Commun; 2017 Feb; 38(2):164-169. PubMed ID: 27893588
[TBL] [Abstract][Full Text] [Related]
7. PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease.
Rinne JO; Laihinen A; Rinne UK; Någren K; Bergman J; Ruotsalainen U
Mov Disord; 1993 Apr; 8(2):134-8. PubMed ID: 8474478
[TBL] [Abstract][Full Text] [Related]
8. [Striatal dopamine D2 receptor in Parkinson disease and its related disorders assessed by C-11 NMSP and PET].
Momose T; Sasaki Y
Nihon Rinsho; 1997 Jan; 55(1):227-32. PubMed ID: 9014455
[TBL] [Abstract][Full Text] [Related]
9. Lateralized differences in iodine-123-IBZM uptake in the basal ganglia in asymmetric Parkinson's disease.
Knable MB; Jones DW; Coppola R; Hyde TM; Lee KS; Gorey J; Weinberger DR
J Nucl Med; 1995 Jul; 36(7):1216-25. PubMed ID: 7790947
[TBL] [Abstract][Full Text] [Related]
10. Models for in vivo kinetic interactions of dopamine D2-neuroreceptors and 3-(2'-[18F]fluoroethyl)spiperone examined with positron emission tomography.
Bahn MM; Huang SC; Hawkins RA; Satyamurthy N; Hoffman JM; Barrio JR; Mazziotta JC; Phelps ME
J Cereb Blood Flow Metab; 1989 Dec; 9(6):840-9. PubMed ID: 2531147
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography in degenerative disorders of the dopaminergic system.
Karbe H; Holthoff V; Huber M; Herholz K; Wienhard K; Wagner R; Heiss WD
J Neural Transm Park Dis Dement Sect; 1992; 4(2):121-30. PubMed ID: 1571076
[TBL] [Abstract][Full Text] [Related]
12. Regional kinetics of [11C]methylspiperone in the brain studied by positron emission tomography in patients with Parkinson's disease.
Hägglund J; Aquilonius SM; Bergström K; Eckernäs SA; Hartvig P; Lundqvist H; Långström B; Malmborg P; Någren K
Adv Neurol; 1987; 45():99-101. PubMed ID: 2950732
[No Abstract] [Full Text] [Related]
13. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
Arahata Y; Kato T; Tadokoro M; Sobue G
Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454
[TBL] [Abstract][Full Text] [Related]
14. Striatal [11C]-N-methyl-spiperone binding in patients with focal dystonia (torticollis) using positron emission tomography.
Leenders K; Hartvig P; Forsgren L; Holmgren G; Almay B; Eckernäs SA; Lundqvist H; Långström B
J Neural Transm Park Dis Dement Sect; 1993; 5(2):79-87. PubMed ID: 8101445
[TBL] [Abstract][Full Text] [Related]
15. A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography.
Huang SC; Bahn MM; Barrio JR; Hoffman JM; Satyamurthy N; Hawkins RA; Mazziotta JC; Phelps ME
J Cereb Blood Flow Metab; 1989 Dec; 9(6):850-8. PubMed ID: 2531148
[TBL] [Abstract][Full Text] [Related]
16. Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism.
Dethy S; Van Blercom N; Damhaut P; Wikler D; Hildebrand J; Goldman S
Mov Disord; 1998 Mar; 13(2):275-80. PubMed ID: 9539341
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 receptor binding and cerebral glucose metabolism recover after D-penicillamine-therapy in Wilson's disease.
Schlaug G; Hefter H; Nebeling B; Engelbrecht V; Weiss P; Stöcklin G; Seitz RJ
J Neurol; 1994 Oct; 241(10):577-84. PubMed ID: 7836960
[TBL] [Abstract][Full Text] [Related]
18. [Functional imaging for disorders of basal ganglia].
Otsuka M; Taniwaki T
Rinsho Shinkeigaku; 1999 Jan; 39(1):30-2. PubMed ID: 10377793
[TBL] [Abstract][Full Text] [Related]
19. Correlation of clinical response in apomorphine test with D2-receptor status as demonstrated by 123I IBZM-SPECT.
Schelosky L; Hierholzer J; Wissel J; Cordes M; Poewe W
Mov Disord; 1993 Oct; 8(4):453-8. PubMed ID: 8232354
[TBL] [Abstract][Full Text] [Related]
20. The dopamine D2 receptor ligand 18F-desmethoxyfallypride: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism.
Schreckenberger M; Hägele S; Siessmeier T; Buchholz HG; Armbrust-Henrich H; Rösch F; Gründer G; Bartenstein P; Vogt T
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1128-35. PubMed ID: 15042325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
